Showing results (1271-1280 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|August 5, 2021
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular CarcinomaBaek-Yeol Ryoo, Daniel H Palmer, Sook Ryun Park, et al.Clinical Drug Investigation|May 24, 2020
New Oral Anticoagulants for Thromboprophylaxis in Patients with Cancer Receiving Chemotherapy: An Economic Evaluation in a Chinese SettingJiangyang Du, Bin WuClinical Drug Investigation|August 20, 2022
Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory CareMichiel Delesie, Arne Ballet, Cedric Hillegeer, et al.Clinical Drug Investigation|August 24, 2022
Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional VariancesSun Jung Kim, Mar Medina, Jongwha ChangClinical Drug Investigation|May 18, 2020
An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USAArielle G Bensimon, Zheng-Yi Zhou, Madeline Jenkins, et al.Clinical Drug Investigation|April 11, 2020
Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World StudyJuan Antonio García-Carmona, Jorge Simal-Aguado, María Pilar Campos-Navarro, et al.Clinical Drug Investigation|July 1, 2015
Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical TrialArash Mowla, Laaya Ahmadzadeh, Leila Razeghian Jahromi, et al.Clinical Drug Investigation|May 27, 2020
Acute Renal Failure, Ketoacidosis, and Urogenital Tract Infections with SGLT2 Inhibitors: Signal Detection Using a Japanese Spontaneous Reporting DatabaseYukari Katsuhara, Toshio OgawaClinical Drug Investigation|April 22, 2020
Comparison of Anti-factor Xa Activity Among Three Different Factor Xa Inhibitors in Non-valvular Atrial Fibrillation Patients with Renal ImpairmentAkihiro Tobe, Hiroyuki Osanai, Akihito Tanaka, et al.Clinical Drug Investigation|September 17, 2021
Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in ThailandRungroj Krittayaphong, Unchalee PermsuwanPageof 234